Faith L. Charles
Director · CNS Pharmaceuticals, Inc.
- 2024
- May 20, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Faith L. Charles files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Andrew Taylor - $2.95M in CDT purchases and sales in the last 12 months
- Vishwas Seshadri - $1.51M in ABEO purchases and sales in the last 12 months
- Joseph Walter Vazzano - $599K in ABEO purchases and sales in the last 12 months
- Mark Alvino - $275K in ABEO purchases and sales in the last 12 months
- Madhav Vasanthavada - $264K in ABEO purchases and sales in the last 12 months
- Brendan M. O'Malley - $251K in ABEO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Faith L. Charles?
Faith L. Charles is a corporate insider, tracked as Director of CNS Pharmaceuticals, Inc. (CNSP). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Faith L. Charles last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 6 filings going back to 2024.
Has Faith L. Charles been buying or selling stock?
Recorded transactions: 1 open-market purchase ($34K) and 1 open-market sale ($63K) across all tracked filings.
